Viewpoint Molecular Targeting to merge with Isoray Inc.

Pending final approval, Viewpoint Molecular Targeting will merge with Richland, Washington-based medtech company Isoray Inc.
Pending final approval, Viewpoint Molecular Targeting will merge with Richland, Washington-based medtech company Isoray Inc. CREDIT VIEWPOINT MOLECULAR TARGETING
Coralville-based Viewpoint Molecular Targeting, a radiopharmaceutical company developing alpha-particle therapies and diagnostic imaging agents, is expected to merge with Isoray Inc., a medical technology company specializing in seed brachytherapy and headquartered in Richland, Washington. According to the terms of the agreement, a newly formed wholly owned subsidiary of Isoray will merge with and into Viewpoint, […]
Already a subscriber? Log in

Want to Read More?

Get immediate, unlimited access to all subscriber content and much more.
Learn more in our subscriber FAQ.

Subscribe Now